Radiation Oncology/Therapy

Pooled evidence: Lu-177 PSMA-617 versus established therapies in mCRPC

By Will Morton

Lu-177 PSMA-617 has a 36% relative reduction in risk of progression versus standard therapies.

February 18, 2026

UNC Health to install Mevion’s proton therapy system

By AuntMinnie.com staff writers

UNC Health will install Mevion's S250-FIT after converting a treatment room to support proton therapy in its established oncology ecosystem.

February 17, 2026

Study questions routine use of radiotherapy after bone surgery

By Will Morton

Findings suggest a possible hazard associated with postoperative radiotherapy.

February 13, 2026

Siemens, Northwestern to collaborate on precision cancer care

By AuntMinnie.com staff writers

The two organizations plan to establish a global center of excellence in theranostics.

February 9, 2026

Public-private EU consortium awarded $18M for cancer research

By AuntMinnie.com staff writers

The PreciseOnco consortium has been awarded $17.6 million from the EU’s Innovative Health Initiative for precision cancer treatment.

February 4, 2026

ASTRO and ESTRO mark World Cancer Day

By AuntMinnie.com staff writers

Today’s radiotherapy is a far more precise, effective, and patient-centered treatment than ever before, according to the groups.

February 4, 2026

Nucs AI establishes medical advisory board

By AuntMinnie.com staff writers

Nucs AI has formed its medical advisory board to ensure the company's AI theranostics tech is aligned with clinical practice.

January 29, 2026

ASTRO launches national radiopharmaceutical therapy training centers

By AuntMinnie.com staff writers

ASTRO has launched a national program creating Authorized User Training Centers for radiopharmaceutical therapy education.

January 29, 2026

Nuclidium wins patent for Cu-61-based radiodiagnostic program

By AuntMinnie.com staff writers

The patent protects the copped-61 (Cu-61)-based diagnostic as well as its use in combination with Cu-67.

January 26, 2026

Elekta secures U.S. FDA 510(k) clearance for Evo

By AuntMinnie.com staff writers

The company is moving forward with Elekta Evo CT-Linac.

January 16, 2026

Alliance for Clinical Trials in Oncology launches prostate cancer trial

By AuntMinnie.com staff writers

The phase III trial, called RECIPROCAL, will include 1,500 patients with metastatic, castration-resistant prostate cancer.

January 5, 2026

What are Pluvicto discontinuation rates in a real-world setting?

By Will Morton

There is a critical need to predict nonresponders and potential discontinuers prior to treatment.

January 5, 2026

Page 1 of 468

Next Page